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of an extracellular function of poly(ADP-
ribose).
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Poly(ADP-ribose) polymerase 1 (PARP1) synthesizes
poly(ADP-ribose) (PAR), an essential post-transla-
tional modification whose function is important in
many cellular processes including DNA damage
signaling, cell death, and inflammation. All known
PAR biology is intracellular, but we suspected it
might also play a role in cell-to-cell communication
during inflammation. We found that PAR activated
cytokine release in human andmouse macrophages,
a hallmark of innate immune activation, and deter-
mined structure-activity relationships. PAR was
rapidly internalized by murine macrophages, while
the monomer, ADP-ribose, was not. Inhibitors of
Toll-like receptor 2 (TLR2) and TLR4 signaling
blocked macrophage responses to PAR, and PAR
induced TLR2 and TLR4 signaling in reporter cell
lines suggesting it was recognized by these TLRs,
much like bacterial pathogens. We propose that
PAR acts as an extracellular damage associated
molecular pattern that drives inflammatory signaling.
INTRODUCTION
Poly(ADP-ribose) (Figure 1A), a unique post-translational modi-
fication, is synthesized by poly(ADP-ribose) polymerases
(PARPs). ADP-ribose subunits are attached to acceptor proteins
using NAD+ as a substrate (Diefenbach and Burkle, 2005). Addi-
tional ADP-ribose subunits are added to elongate the chain
(Altmeyer et al., 2009). Chain length is variable and up to 200
units in length in vitro (D’Amours et al., 1999). Inside cells, PAR
chains are rapidly cleaved by poly(ADP-ribose) glycohydrolase
(PARG), TARG1, and other hydrolases such as phosphodiester-
ases (PDE) (Figure 1A) (Diefenbach and Burkle, 2005; Hassa and
Hottiger, 2008; Perina et al., 2014). However, PAR is chemically
quite stable. It is stable in 1 M NaOH (Tan et al., 2012) and might
persist longer in the extracellular space. Notably, all proposed
functions of PAR are inside the cell. Possible extracellular
biology has not been investigated to our knowledge.
PAR and PARPs have been most studied in the DNA damage
response. PARP1, the most abundant family member, is acti-
vated by direct binding to strand breaks (Langelier et al., 2012;446 Chemistry & Biology 22, 446–452, April 23, 2015 ª2015 ElsevierTallis et al., 2014), increasing PARP1 activity 10- to 500-fold
(D’Amours et al., 1999). Activation leads to modification of
PARP1 itself and other proteins in the DNA repair pathway
(Chapman et al., 2013; Daniels et al., 2014; Jungmichel et al.,
2013; Zhang et al., 2013). It has been hypothesized that exces-
sive DNA damage leads to PARP1-dependent cell death via
necrosis (Ha and Snyder, 1999), whereas PARP1 is cleaved
and inactivated early in apoptosis (Kaufmann et al., 1993).
We hypothesized that PAR acts as a signaling molecule alert-
ing the innate immune system to necrotic cells. PAR shares
some structural motifs with DNA and ATP, both of which, when
exposed to the extracellular space, stimulate phagocytosis via
monocyte-derived dendritic cells (Cohen and Mosser, 2013;
Haag et al., 2007; Kroemer et al., 2013). Could PAR be a sub-
strate for extracellular receptors and act as an additional signal?
To test this hypothesis, we treated mouse macrophages and
primary human macrophages with purified PAR and found that
PAR activated both mouse and humanmacrophages. This study
suggested that extracellular PAR could promote phagocytosis of
PAR-modified cell debris and inflammatory cytokine production
by immune cells.RESULTS
Extracellular PAR Activates a Mouse Macrophage
Cell Line
Macrophages respond to infection or cellular damage by engulf-
ing foreign cells, dead cells, or debris. They detect molecular
patterns and in response, secrete pro- or anti-inflammatory
cytokines, orchestrating innate immune and inflammatory re-
sponses (Murray and Wynn, 2011). To determine if extracellular
PAR could activate macrophages, we treated a standard mouse
macrophage cell line (RAW264.7) with enzymatically synthesized
and purified PAR (Tan et al., 2012) in the medium and measured
secretion of 23 cytokines (Figure 1B). PAR strongly stimulated
secretion of tumor necrosis factor alpha (TNFa), MCP-1, eotaxin,
MIP-1a, and MIP-1b, all pro-inflammatory cytokines that are
stimulated by the pathogen-associated molecular patterns
(PAMPs) lipopolysaccharide (LPS), CpG DNA, and poly(I-C)
RNA, known activators of innate immune responses (Caskey
et al., 2011; Ha¨cker et al., 2002).
RAW264.7 cells are sensitive to low levels of bacterial
endotoxins such as LPS. To exclude the possibility that our
purified PAR had endotoxin contamination, we digested purified
PAR with snake venom PDE or bovine PARG and treatedLtd All rights reserved
Figure 1. PAR Induces Cytokine Secretion
in RAW264.7 Cells
(A) Structure of PAR and cleavage sites for PARG
and PDE.
(B) Multiplexed profiling of secreted mouse cyto-
kines from RAW264.7 cells was performed in
control cells or after treatment with 30 mM CpG
DNA, 30 mM poly(I-C) RNA, 30 mM PAR, or 30 mM
PAR digested with PDE.
(C) Cells were treated for 4 hr with PAR, PDE-
digested PAR, PDE alone, PARG-digested PAR,
or PARG alone. Secreted TNFa is represented as
the mean ± SD and n = 4.
(D) RAW 264.7 cells were treated with PAR for
given times. Secreted TNFa is represented as the
mean ± SD and n = 3.RAW264.7 cells with the digested polymer. Neither PDE nor
PARG alone induced TNFa secretion when added to cells, and
PAR digestion led to reduced TNFa and MCP-1 secretion upon
treatment (Figures 1B and 1C; Figure S1). We concluded
that macrophage activation was not caused by endotoxin
contamination.Chemistry & Biology 22, 446–452, April 23, 2015TNFa showed the most robust and
PAR-specific response in a panel of 23
mouse cytokines (Figure 1B). It is also
an extremely important pro-inflammatory
cytokine in humans. We focused on
experiments using TNFa secretion as a
readout. First, we treated RAW264.7 cells
with increasing concentrations of PAR
for 2 and 4 hr and measured the secretion
of TNFa. TNFa secretion showed a
robust time and dose dependence for
PAR (Figure 1D). PAR concentrations
in all plots are expressed in units of the
monomer, ADP-ribose.
We next explored the structure-activity
relationship between PAR and immune
cell activation. We observed no TNFa
secretion with single ADP-ribose sub-
units, nicotinamide, or NAD+. We also
tested poly-deoxyriboadenosine (poly-
dA) and poly-riboadenosine (poly-rA),
which were 20 units in length, and cyclic
ADP-ribose (cADPr), a known secondary
messenger. Thesemolecules have similar
structural motifs to PAR but did not
induce TNFa secretion (Figures 2A and
2B). These experiments suggested that
RAW264.7 macrophages recognized a
specific structural moiety found in PAR.
To better define the stimulatory motif
for RAW264.7 cells, we explored the
size requirements for PAR-dependent
activation of these cells. By treating cells
with size-fractionated PAR (Tan et al.,
2012), we found that small (2- to 17-mer),
medium (18- to 40-mer), and large (>40-mer) polymers induced TNFa secretion (Figure 2C). Because
PAR concentration is expressed in units of the monomer, the
concentration of polymer decreases as size increases. This
may account for the decrease in TNFa secretion seen with longer
polymers. We also tested purified PAR dimers and trimers, and
both induced TNFa secretion as well as bulk polymer (Figure 2D).ª2015 Elsevier Ltd All rights reserved 447
Figure 2. A Dimer of PAR Is Sufficient to
Induce TNFa Secretion
(A and B) Structurally similar compounds to PAR
(A) were added to RAW264.7 cells and secreted
TNFa was measured (B). Cells were treated for
4 hr. Data represent one of three independent
experiments.
(C) Size-fractionated PAR was added to cells for
4 hr before TNFa secretion was measured. Data
represent one of two independent experiments.
(D) Bulk PAR, a dimer or a trimer of ADP-ribose
was incubated with RAW cells for 4 hr before
secreted TNFa was measured.We concluded that PAR activated RAW264.7 macrophages in
a manner similar to known PAMPs. We also concluded that
RAW264.7 cells recognized a structural motif found in a dimer
of PAR, i.e. the shortest polymer that has the unique 20-100
ribose-ribose linkage characteristic of PAR (Figure 2A). Iso-
ADP-ribose, the digestion product of PDE (Figure 1A), contains
the 20-100 ribose-ribose linkage. The loss of activity of PDE-
digested PAR (Figure 1C; Figure S1) indicated that RAW264.7
cells recognized more than just the ribose-ribose linkage.
PAR Acts through Toll-like Receptors to Activate
Macrophages
We next explored the mechanism of PAR-dependent TNFa
secretion. TNFa secretion is often activated in response to
signaling via Toll-like receptors (TLRs), a major family of pattern
recognition receptors (Akira and Takeda, 2004). TLR signaling
often occurs during or after endocytosis of the PAMP bound
to its cognate TLR (Takeda and Akira, 2005). To test if PAR is448 Chemistry & Biology 22, 446–452, April 23, 2015 ª2015 Elsevier Ltd All rights reservedinternalized by cells, we incubated
RAW264.7 cells with PAR labeled with
the TAMRA fluorophore and measured
uptake. High-performance liquid chroma-
tography characterization of TAMRA-
PAR is shown in Figure S2A. Cells incu-
bated with TAMRA-labeled ADP-ribose
and thenwashed briefly exhibited no fluo-
rescent signal, whereas cells incubated
with TAMRA-PAR exhibited a fluorescent
signal within 15 min of incubation (Figures
3A and 3B). Similar results were seen
with unlabeled PAR visualized by immu-
nofluorescence (Figure S2B). Immuno-
fluorescence of the PAR-treated cells
with the anti-PAR 10H antibody indicated
that the internalized PAR remained intact
(Figure S2B and S2D). To confirm that
TAMRA-PAR behaved like unlabeled
PAR, we measured TNFa secretion after
TAMRA-PAR treatment. TAMRA-PAR
induced TNFa secretion and secretion
was blocked by digestion of TAMRA-
PAR with PARG (Figure S2E). Uptake
of TAMRA-PAR was also blocked by
pre-digestion of the polymer with PDE
(Figures 3C and 3D).The internalized PAR signal localized to punctate structures
throughout the cytoplasm that concentrated near the nucleus.
This is the morphology expected for endosome compartments.
Staining with endosomal markers showed partial co-localization
with the early endosomal marker EEA1 and no co-localization
with the late endosomal marker LAMP1 (Figures 3E and 3F).
We also presented ADP-ribose or PAR attached to latex beads
and performed time-lapse imaging of the cells for 3 hr after addi-
tion of the beads to the medium. RAW264.7 cells preferentially
phagocytosed PAR-labeled beads (Figures 3C and S3; Movies
S1 and S2).
To test the role of TLRs, we treated cells with small molecules
that block TLR signaling. Pre-treatment of cells with the oxidized
phospholipid oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-
phosphorylcholine (OxPAPC), which inhibits TLR2 and TLR4 by
binding to specific adaptor proteins and preventing ligand bind-
ing (Erridge et al., 2008), dramatically reduced both TNFa secre-
tion and labeling of cells with fluorescent PAR (Figures 4A–4C).
Figure 3. PAR but Not ADP-ribose Is Taken Up by RAW264.7 Cells
(A) Raw264.7 cells were treated with 20 mg/ml TAMRA-PAR for indicated times. Representative images are shown with a scale bar representing 10 mm.
(B) Quantification of uptake is shown as the mean intensity per cell ± SD with nR 20 cells. Data represent one of three independent experiments.
(C) Cells were treated with 20 mg/ml TAMRA-PAR or PDE-digested TAMRA-PAR for 1 hr. Representative images are shown with a scale bar representing 10 mm.
(D) Quantification of uptake is shown as mean intensity per cell ± SD with nR 25.
(E and F) Cells treated with 20 mg/ml TAMRA-PAR for 1 hr were subsequently stained for (E) EEA1 (BD Biosciences) or (F) LAMP1 (Abcam). Arrowheads highlight
colocalization between TAMRA-PAR and EEA1.
(G) ADP-ribose (ADPr) or PAR conjugated latex beads were incubated with RAW264.7 cells and imaged for 3 hr at 1-min intervals. Stills at given times are shown
with a scale bar representing 10 mm. See also Movies S1 and S2 and Figure S3 where bead uptake was quantified with confocal imaging.
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Figure 4. TLR2/TLR4 Are Required for Acti-
vation of both Mouse and Human Macro-
phages
(A) Cells, pretreated with vehicle, 30 mg/ml
OxPAPC, or 100 mM chloroquine for 1 hr, were
incubated with TAMRA-PAR for 30 min. Scale bar
represents 10 mm.
(B) Quantification from one of two independent
experiments is shown as the mean intensity per
cell ± SD with nR 20.
(C) Cells were pretreated with vehicle, 30 mg/ml
OxPAPC, or 100 mM chloroquine for 1 hr and then
incubated with PAR for 4 hr. Data represent mean
TNFa secretion ± SD and n = 4.
(D) 293 NFkB reporter cells expressing no receptor
(control), TLR2, or TLR4 were treated with a TLR2-
specific agonist, LTA-BS, a TLR4-specific agonist,
LPS-B5, PAR, or ADPr. Luciferase activity was
normalized by the mean of the medium-alone
condition. Results are shown as the mean ± SD
and n R 4. The p-value, as compared to media
alone, was calculated using an unpaired t test with
Welch’s correction. ** = p-value between 0.001
and 0.01, ns = p-value >0.05.
(E) Primary human monocytes and macrophages
were treated with PAR for 6 hr before the
medium was collected and analyzed for TNFa.
For the second of two independent experiments,
see Figure S4.
(F) Primary human monocytes and macrophages
were pretreated with 30 mg/ml OxPAPC for 1 hr
followed by 30 mM PAR or 1 mg/ml of LPS for 6 hr.
For the second of two independent experiments,
see Figure S4.Chloroquine, an inhibitor of endosomal acidification, which also
disrupts TLR signaling by binding nucleic acid ligands (Kuznik
et al., 2011), also reduced PAR-induced TNFa secretion but to
a lesser extent than OxPAPC. Chloroquine also inhibited labeling
of cells with TAMRA-PAR.
To test the requirement for TLR2versusTLR4,we treatedNFkB-
luciferase reporter cell lines expressing either TLR2 or TLR4
with PAR. Both cell lines responded to PAR while a cell line
expressing only the NFkB-luciferase reporter did not (Figure 4D)
indicating that PAR can signal through both TLR2 and TLR4.
Extracellular PAR Activates Specific Human
Macrophage Types
To test if PAR activates human primary immune cells, we isolated
monocytes, precursors of macrophages, from human blood,450 Chemistry & Biology 22, 446–452, April 23, 2015 ª2015 Elsevier Ltd All rights reserveddifferentiated them into macrophages
(M0) with M-CSF and into M1 and M2
polarized macrophages using LPS/inter-
feron-g and IL-4, respectively. We treated
the resulting four monocyte/macrophage
types with PAR, and found that M0
and M2 macrophages responded to
PAR by secreting TNFa, while monocytes
andM1macrophages did not (Figures 4E,
4F, and S4). Secretion of TNFa from M0
and M2 macrophages was blocked byOxPAPC, suggesting a similar TLR2- or TLR4-dependent mech-
anism as seen in the mouse macrophage line (Figures 4E and
S4B). We concluded that PAR is also a strong pro-inflammatory
signal for certain primary human monocyte-derived lineages.
DISCUSSION
In this study, we found that highly purified PAR added to the
medium activated both mouse and human macrophages to
secrete pro-inflammatory cytokines. The activation was dose
dependent and was strongly decreased by enzymatic pre-
hydrolysis of PAR. It required a minimum of two subunits, sug-
gesting that a cell surface receptor is recognizing, at least in
part, the ribose-ribose linkage unique to PAR among standard
biomolecules. TLRs are a main class of receptors for innate
immune response activation in macrophages (Cohen and
Mosser, 2013; Takeda and Akira, 2005). The PAR-dependent
cytokine profile closely resembled the profiles for known binders
and activators of TLRs, LPS, CpG DNA, and poly(I-C) RNA
(Wang et al., 2014). PAR triggered uptake of labeled beads or
internalization of fluorescently labeled PAR, and an inhibitor of
TLR2 and TLR4, OxPAPC, blocked PAR-dependent TNFa secre-
tion and the uptake of fluorescently labeled PAR. PAR induced
NFkB signaling in both TLR2 and TLR4 reporter cell lines indi-
cating that PAR can signal through both receptors. OxPAPC
almost completely blocked TNFa secretion suggesting that
PAR mainly signaled through either TLR2 or TLR4.
An interesting question is whether, and if so how, PAR makes
its way to the extracellular space. PAR antibodies have been
found in the serum of patients with Alzheimer disease and
systemic lupus erythematosus (Kanai and Sugimura, 1981;
Kanai et al., 2007) suggesting that PAR can become extracel-
lular in humans. One model is that excessive activation of
PARP1 through oxidative stress or DNA damage leads to cell
death by necrosis. Necrotic death would expose PAR-modified
acceptor proteins, or free PAR that has been cleaved off
acceptors, to the extracellular space. PAR could also be
made extracellularly. ART2, an enzyme found on the surface
of T cells, was recently shown to synthesize PAR (Morrison
et al., 2006).
The recognition of PAR by macrophages may serve multiple
biological purposes. One possibility is that this represents
an alternative mechanism for activation of the innate immune
response by the DNA damage response. DNA damage response
signaling is known to be involved in the production of pro-inflam-
matory signals from damaged cells (Chatzinikolaou et al., 2014).
Unrepaired DNA damage can also trigger apoptosis generating
many new DNA strand breaks through activation of caspase-
activated DNase nuclease (Samejima and Earnshaw, 2005).
PARP1 itself is cleaved early during apoptosis (Kaufmann
et al., 1993) for unknown reasons. An interesting possibility is
that high PARP1 activity due to caspase-activated DNase-
induced strand breaks would otherwise generate a lot of PAR,
and if pro-inflammatory, this PAR would be problematic for the
physiology of apoptosis. Apoptosis is thought to be a form of
cell death that is not pro-inflammatory, unlike necrosis, which
is highly pro-inflammatory.SIGNIFICANCE
Overall, this study elucidated a novel extracellular function
for PAR and provides an exciting connection between
PAR, PARP activity, and the innate immune system. The
link between PAR and the innate immune systems warrants
further study and presents exciting possibilities for the role
of PAR in inflammation and cancer.EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
RAW264.7 cells (ATCC), 293-NFkB-Luc, 293-TLR4HA-MD2-CD14-NFkB-
Luc, 293-TLR2-FLAG-NFkB-Luc cell lines were grown in DMEM (Medi-
atech/Corning) with 10% FBS (Gibco) and 1% penicillin/streptomycin
(Mediatech/Corning). Isolation and manipulation of primary human immuneChemistry & Biology 22,cells were adapted from Martinez et al. (2006). For more details, see Supple-
mental Information.
PAR used in this study was purified and fractionated as previously described
by Tan et al. (2012). TAMRA (Life Technologies)-labeled PAR was synthesized
by coupling the carboxyl group on TAMRA with the free amine on PAR
using N-(3-dimethylaminopropyl)-N0-ethylcarbodiimide hydrochloride or
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM,
Oakwood Products) as coupling reagents. For more details, see Supplemental
Information. For PAR digestions, PAR was incubated with either 13 ng/ml
bovine PARG (Enzo Life Sciences) or 2 mg/ml PDE (Affymetrix) for 2 hr at
37C in 100 mM Tris buffer (pH 8.0).
Multiplex Cytokine Analysis
RAW264.7 cells were seeded in 96-well plates and allowed to adhere over-
night. Medium was then exchanged for medium containing either PAR, LPS
(Sigma), CpGDNA (Invivogen), or poly(I-C) RNA (Invivogen). At each time point,
medium was collected and frozen at 80C until further analysis. Secreted
cytokines were measured using the Bio-Plex Pro Mouse Cytokine 23-plex
Assay (Bio-Rad) and FlexMap3D (Luminex) following the manufacturer’s
instructions.
TNFa ELISA Assay
Cells were seeded in 96-well plates a day before treatment at a density of
1 3 105 cells/ml. Medium was exchanged for medium containing PAR
and other stimulants. After treatment, medium was collected and stored
at 80C until analysis. Levels of secreted TNFa were measured using the
BioLegend TNFa ELISA kit according to the manufacturer’s instructions.
NFkB Reporter Assay
Cells were seeded in 96-well plates a day before treatment at a density of
1 3 105 cells/ml. Cells were treated with 30 mM PAR, 100 ng/ml LTA-BS
(Invivogen), 1 ng/ml LPS-B5 ultrapure (Invivogen), or 30 mM ADPr for 24 hr.
Luciferase activity was determined using the Promega Luciferase Assay
system according to the manufacturer’s instructions.
Imaging
For confocal imaging, Raw264.7 cells were seeded onto coverslips. After
a day, cells were treated with TAMRA-labeled PAR for 30 min in a 37C incu-
bator and washed twice with PBS to remove residual PAR. Cells were fixed
with 4% formaldehyde for 15–20 min at room temperature and kept in PBS
during imaging or mounted with Prolong Gold Mounting Media (Invitrogen).
Images at up to five random positions per condition were obtained. For
quantification of PAR uptake, cell edges were outlined and fluorescent inten-
sity was analyzed in single cells using ImageJ.
For live cell imaging, ADP-ribose (Sigma) and purified PAR were conjugated
to 1 mm carboxylated latex beads (Sigma) using DMTMM as a coupling
reagent (see Supplemental Information). 2.5 3 105 beads/ml were added to
cells growing in MatTek glass-bottom tissue culture plates and imaged.
See Supplemental Information for more information on the microscope
systems used.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2015.03.007.
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